Marketing authorisation
Marketing authorisation is a legal status that allows the commercial distribution and sale of a pharmaceutical product within a specified jurisdiction. It is granted by a regulatory authority after a thorough evaluation of the product's safety, efficacy, and quality.
Overview
Marketing authorisation is a critical step in the drug development process. It is the final stage before a new medicine can be introduced to the market. The process involves a comprehensive review of the clinical trial data, manufacturing process, and labelling of the product.
Process
The process for obtaining marketing authorisation varies by jurisdiction. In the European Union, the European Medicines Agency (EMA) is responsible for the centralised procedure. In the United States, the Food and Drug Administration (FDA) grants marketing authorisation.
Application
The applicant, usually a pharmaceutical company, submits a dossier containing all relevant information about the product. This includes results from preclinical studies, clinical trials, information on manufacturing, and proposed labelling and package inserts.
Review
The regulatory authority reviews the application to determine whether the product meets the necessary standards of safety, efficacy, and quality. This review process can take several months to years, depending on the complexity of the product and the completeness of the application.
Decision
If the regulatory authority determines that the benefits of the product outweigh its risks, it grants marketing authorisation. This allows the product to be sold and marketed within the jurisdiction.
Post-authorisation activities
After a product has received marketing authorisation, the manufacturer is required to conduct post-marketing surveillance to monitor the product's safety and efficacy in the general population. This includes reporting any adverse events and conducting post-marketing studies if necessary.
See also
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD